Anton Kollisch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Profit In A $29 Billion New Biotech Sector
I came of age in the late 1960s and early 1970s, which means I’m no stranger to recreational drugs, from pot to psychedelics. Like, I’ve seen things, man… and I could tell you some stories. Through it all, though, I was fascinated with the idea of psychedelics. I still am.
Tough to believe, but back then, LSD was still legal; research was going full-bore. And I understood these drugs had promise - real promise.
Please share this article - Go to very top of page, right hand side, for social media buttons. ....

New York , United States , City Of , United Kingdom , San Francisco , Jean Dybowsky , Edouard Landrin , Jennifer Mitchell , Albert Hofmann , Anton Kollisch , John Hopkins , Shah Gilani , University Of California , Psychedelic Research Publications , Multidisciplinary Association For Psychedelic Studies , Drug Administration , United Nations , Us Drug Enforcement Agency , New York Times , Market Research , Imperial College London , Pfizer Inc , Researchandmarkets Inc , Moderna Inc , Health Canada , Chief Investment ,